-
Advancement of First-Line Treatments on EGFR-Mutated NSCLC
18 Jan 2025 00:27 GMT
… Hospitals Cleveland Medical Center; Giselle Dutcher, MD,medical oncologist at … ] is an important subcategory drug. I have had a … line treatment based on the phase 3 MARIPOSA-2 trial [ … gefitinib [Iressa] or erlotinib [Tarceva]. Gefitinib [was used] mainly …
-
NSCLC Experts Ponder Best First-Line Treatment Options
18 Jan 2025 00:27 GMT
… out of recent clinical trials, particularly involving a combination … trial criteria for patients for whom they recommend the treatment … at Trinity Health IHA Medical Group; and Tarik Hadid … [added chemotherapy] to erlotinib [Tarceva] a lot back in the …
-
University of Chicago Thought Process on First-line Treatment in EGFR NSCLC
18 Jan 2025 00:27 GMT
… ) trials.1-3 The panelists focused on how each treatment regimen … MD, associate professor of medicine. Additional panelists included James … gefitinib [Iressa] or erlotinib [Tarceva]. The median progression-free … trial was to look at arm A vs arm B. The FDA …
-
Chugai Pharma to transfer future marketing of anti─cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
15 Jan 2025 05:09 GMT
… the marketing authorization regarding Tarceva.
Chugai Pharmaceutical Co., Ltd., headquartered … research-based pharmaceutical company with world-class drug discovery capabilities, … well-established medicines from the research-based pharmaceutical industry and …
-
FLAURA/FLAURA2 Regimens as Treatment Options for NSCLC
03 Jan 2025 01:19 GMT
… out of recent clinical trials, particularly involving a combination … (Tagrisso) and chemotherapy. The doctors delve into the pros and … chemotherapy as a next-line [treatment] when they [have disease … [added chemotherapy] to erlotinib [Tarceva] a lot back in the …
-
Afatinib/Osimertinib Treatment Combinations in EGFR-Mutated Advanced NSCLC
31 Dec 2024 13:28 GMT
… Hospitals Cleveland Medical Center; Giselle Dutcher, MD,medical oncologist at … ] is an important subcategory drug. I have had a … line treatment based on the phase 3 MARIPOSA-2 trial [ … gefitinib [Iressa] or erlotinib [Tarceva]. Gefitinib [was used] mainly …
-
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
Approval Date
Reference Listed Drug
Generic Drug Name
NDA Holder
ANDA Applicant
… ;2024
Endari
L-Glutamine
Emmaus Medical
Novitium Pharma
215647
07… ;13/2024
Tarceva
Erlotinib HCl
OSI Pharmaceuticals
Hikma
203843
09…
-
Bumrungrad Health Briefs #42: Targeted Therapy: A Precision Approach to Cancer Treatment
25 Oct 2024 08:51 GMT
… Precision Approach to Cancer Treatment
Cancer treatment is advancing rapidly through … cells.
This form of precision medicine falls into three main categories … be treated with targeted drugs like erlotinib (Tarceva) or gefitinib (Iressa).
Colorectal …
-
Orphan designation: erlotinib Treatment of pachyonychia congenita, 18/07/2022 Positive
02 Oct 2024 15:49 GMT
… medicine';s development, doctors may be able to enrol patients in clinical trials … investigating the medicine. For … medicine is authorised in the EU under the trade name Tarceva for the treatment …
-
Patient-Centered Discussions Will Be Critical to Navigate Treatment Selection in EGFR+ NSCLC
04 Oct 2024 22:35 GMT
… who is a thoracic medical oncologist and assistant attending … FLAURA2 and MARIPOSA trials expanded frontline treatment options for patients … -to drug. It’s shown efficacy over erlotinib [Tarceva] and … FDA approved yet, so it’s still in [early] clinical trial …